Junhui Xia

1.3k total citations · 1 hit paper
20 papers, 500 citations indexed

About

Junhui Xia is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Junhui Xia has authored 20 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 11 papers in Neurology and 7 papers in Rheumatology. Recurrent topics in Junhui Xia's work include Multiple Sclerosis Research Studies (14 papers), Peripheral Neuropathies and Disorders (10 papers) and Systemic Lupus Erythematosus Research (7 papers). Junhui Xia is often cited by papers focused on Multiple Sclerosis Research Studies (14 papers), Peripheral Neuropathies and Disorders (10 papers) and Systemic Lupus Erythematosus Research (7 papers). Junhui Xia collaborates with scholars based in China. Junhui Xia's co-authors include Jie Lin, Lei Zhang, Xuehui Huang, Danlin Fan, Qijun Weng, Bin Han, Qi Feng, Yiqi Lu, Jiaying Chen and Cheng Benyi and has published in prestigious journals such as Nature, Journal of Neurology Neurosurgery & Psychiatry and Frontiers in Immunology.

In The Last Decade

Junhui Xia

20 papers receiving 495 citations

Hit Papers

Genomic architecture of heterosis for yield traits in rice 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junhui Xia China 9 290 211 134 115 100 20 500
Ana Nikolić Serbia 14 305 1.1× 142 0.7× 11 0.1× 19 0.2× 131 1.3× 64 517
Knud Christensen Denmark 10 76 0.3× 187 0.9× 31 0.2× 10 0.1× 153 1.5× 20 393
Anne Sturbaum United States 10 358 1.2× 52 0.2× 18 0.1× 211 1.8× 159 1.6× 14 611
Fedor A. Konovalov Russia 11 172 0.6× 107 0.5× 9 0.1× 6 0.1× 161 1.6× 46 374
Yuichi Miura Japan 9 163 0.6× 51 0.2× 8 0.1× 5 0.0× 158 1.6× 23 416
Yongqiang Wu China 11 125 0.4× 39 0.2× 10 0.1× 18 0.2× 369 3.7× 44 579
Lara Strittmatter United States 12 90 0.3× 89 0.4× 7 0.1× 61 0.5× 324 3.2× 16 505
Bhuwan Khatri United States 10 9 0.0× 42 0.2× 46 0.3× 27 0.2× 172 1.7× 18 331
X Y Wang China 7 45 0.2× 45 0.2× 11 0.1× 5 0.0× 122 1.2× 32 379
Wenxi Wang China 11 263 0.9× 82 0.4× 12 0.1× 4 0.0× 373 3.7× 25 638

Countries citing papers authored by Junhui Xia

Since Specialization
Citations

This map shows the geographic impact of Junhui Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhui Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhui Xia more than expected).

Fields of papers citing papers by Junhui Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhui Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhui Xia. The network helps show where Junhui Xia may publish in the future.

Co-authorship network of co-authors of Junhui Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Junhui Xia. A scholar is included among the top collaborators of Junhui Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhui Xia. Junhui Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Kailun, Xiaoming Yang, Yuanhua Liu, et al.. (2025). A comprehensive study of AAV tropism across C57BL/6 mice, BALB/c mice, and crab-eating macaques. Molecular Therapy — Methods & Clinical Development. 33(1). 101434–101434. 3 indexed citations
2.
Li, Jia, Yiyun Weng, Xu Zhang, et al.. (2024). Effects of early intervention in neuromyelitis optica spectrum disorder patients with seropositive AQP4 antibodies. Frontiers in Immunology. 15. 1458556–1458556. 2 indexed citations
3.
Lin, Jie, Jia Li, Yiyun Weng, et al.. (2024). The relationship between neuromyelitis optica spectrum disorder and autoimmune diseases. Frontiers in Immunology. 15. 1406409–1406409. 3 indexed citations
4.
Huang, Wenjuan, Liang Wang, Junhui Xia, et al.. (2022). Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorder. European Journal of Neurology. 29(8). 2343–2354. 18 indexed citations
5.
Huang, Wenjuan, Junhui Xia, Wenyu Li, et al.. (2022). The description of neuromyelitis optica spectrum disorder: Patient registry in Yangtze River Delta area of China. Multiple Sclerosis and Related Disorders. 66. 104023–104023. 6 indexed citations
6.
Lin, Jie, et al.. (2022). Incidence and risk factors for venous thromboembolism during an acute attack in patients with neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders. 58. 103513–103513. 2 indexed citations
7.
Lin, Jie, Jia Li, Zhibo Chen, et al.. (2022). Comparison of Long-Term Use of Low Dose Rituximab and Mycophenolate Mofetil in Chinese Patients With Neuromyelitis Optica Spectrum Disorder. Frontiers in Neurology. 13. 891064–891064. 2 indexed citations
8.
Lin, Jie, et al.. (2021). Intravenous immunoglobulin as the rescue treatment in NMOSD patients. Neurological Sciences. 42(9). 3857–3863. 14 indexed citations
9.
Wang, Liang, Lei Zhou, Jingzi ZhangBao, et al.. (2020). Neuromyelitis optica spectrum disorder: pregnancy-related attack and predictive risk factors. Journal of Neurology Neurosurgery & Psychiatry. 92(1). 53–61. 15 indexed citations
10.
Xia, Junhui, et al.. (2018). Development of SSR markers based on potato genome sequence and construction of a higher-density linkage map.. Acta Horticulturae Sinica. 45(8). 1551–1562. 1 indexed citations
11.
Lin, Jie, et al.. (2018). Low-dosage of rituximab in Chinese patients with neuromyelitis optica spectrum disorder. Journal of Neuroimmunology. 317. 1–4. 21 indexed citations
12.
Huang, W M, et al.. (2018). Additive and epistatic QTLs underlying the dormancy in a diploid potato population across seven environments. Scientia Horticulturae. 240. 578–584. 5 indexed citations
13.
Lin, Jie, et al.. (2017). Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD. Neurological Sciences. 38(10). 1859–1863. 23 indexed citations
14.
Li, Xiang, Jie Lin, Sipei Pan, et al.. (2017). Suspected bacterial meningomyelitis: The first presenting clinical feature of neuromyelitis optica spectrum disorder. Journal of Neuroimmunology. 309. 68–71. 6 indexed citations
15.
Quan, Weiwei, Junhui Xia, Jie Lin, et al.. (2017). Myasthenia gravis and chronic inflammatory demyelinating polyneuropathy in the same patient – a case report. International Journal of Neuroscience. 128(6). 570–572. 5 indexed citations
16.
Lin, Jie, et al.. (2016). Effects of early using azathioprine in the acute phase in neuromyelitis optica spectrum disorder. International Journal of Neuroscience. 127(6). 508–515. 1 indexed citations
17.
Lin, Jie, et al.. (2016). Th17 cells in neuromyelitis optica spectrum disorder: a review. International Journal of Neuroscience. 126(12). 1051–1060. 39 indexed citations
18.
Huang, Xuehui, Yang Shi-hua, Junyi Gong, et al.. (2016). Genomic architecture of heterosis for yield traits in rice. Nature. 537(7622). 629–633. 309 indexed citations breakdown →
19.
Lin, Jie, et al.. (2016). Monoclonal antibody therapy for neuromyelitis optica spectrum disorder: current and future. International Journal of Neuroscience. 127(8). 735–744. 9 indexed citations
20.
Xia, Junhui. (2009). Progress of Application and Breeding on Two-line Hybrid Rice in China. Zajiao shuidao. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026